Inhibition of alcohol dehydrogenase blocks enhanced Gi-protein expression following ethanol treatment in experimental hepatocellular carcinoma in vitro

European Journal of Gastroenterology and Hepatology

Volumn 13, Issue 10, 2001, Pages 1209-1216

  Kovach, Stephen J ^a   Sitzmann, James V ^a   McKillop, Iain H ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

4 methyl pyrazole; Acetaldehyde; Ethanol; G proteins; Hepatocellular carcinoma

Indexed keywords

4 METHYLPYRAZOLE; ACETALDEHYDE; ALCOHOL; ALCOHOL DEHYDROGENASE; ALCOHOL DERIVATIVE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA;

ALCOHOL METABOLISM; ANIMAL CELL; ARTICLE; ASSAY; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; IN VITRO STUDY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TIME;

ALCOHOL DEHYDROGENASE; ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; ETHANOL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GTP-BINDING PROTEINS; HUMANS; LIVER NEOPLASMS; MODELS, ANIMAL; RATS; TUMOR CELLS, CULTURED;

EID: 0034764545     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/00042737-200110000-00014     Document Type: Article

References (41)

1. Bergsland EK, Venook AP. Hepatocellular carcinoma. Curr Opin Oncol 2000; 12: 357-361.
2. Schafer DF, Sorrell MF. Hepatocellular carcinoma. Lancet 1999; 353: 1253-1257.
3. Yogita S, Tashiro S. Current status of surgical treatment for hepatocellular carcinoma. J Med Invest 2000; 47: 91-100.
4. Yu MC, Yuan JM, Govindarajan S, Ross RK. Epidemiology of hepatocellular carcinoma. Can J Gastroenterol 2000; 14: 703-709.
5. Okuda SJ, Kondo Y. Chapter 128. In: Bockus Gastroenterology (5th edn). Haubrich WS, Schaffner F, Berk JE (editors). Philadelphia, PA: W.B. Saunders; 1995. pp. 2444-2487.
6. Colombo M. Hepatitis C virus and hepatocellular carcinoma. Baillière’s Best Pract Res Clin Gastroenterol 1999; 13: 519-528.
7. Kew MC. Hepatitis viruses and hepatocellular carcinoma. Res Virol 1998; 149: 257-262.
8. Yoshihara H, Noda K, Kamada T. Interrelationship between alcohol intake, hepatitis C, liver cirrhosis, and hepatocellular carcinoma. Recent Dev Alcohol 1998; 14: 457-469.
9. Shibata A, Hirohata T, Toshima H, Tashiro H. The role of drinking and cigarette smoking in the excess deaths from liver cancer. Jpn J Cancer Res 1986; 77: 287-295.
10. McKillop IH, Wu Y, Cahill PA, Sitzmann JV. Altered expression of inhibitory guanine nucleotide regulatory proteins (Gi-proteins) in experimental hepatocellular carcinoma. J Cell Phys 1998; 175: 295-304.
11. Schmidt CM, McKillop IH, Cahill PA, Sitzmann JV. Alterations in guanine nucleotide regulatory protein expression and activity in human hepatocellular carcinoma. Hepatology 1997; 26: 1189-1194.
12. Vaughan M. Signaling by heterotrimeric G proteins: mini review series. J Biol Chem 1998; 273: 667-668.
13. Dhanasekaran N, Tsim ST, Dermott JM, Onesime D. Regulation of cell proliferation by G proteins. Oncogene 1998; 17: 1383-1394.
14. Van Biessen T, Luttrel LM, Hawes BE, Lefkowitz RJ. Mitogenic signaling via G-protein-coupled receptors. Endocr Rev 1996; 17: 698-714.
15. Crespo P, Leon J. Ras proteins in the control of the cell cycle and cell differentiation. Cell Mol Life Sci 2000; 57: 1613-1636.
16. Simonds WF. G protein regulation of adenylate cyclase. Trends Pharmacol Sci 1999; 20: 66-73.
17. Bar-Sagi D, Hall A. Ras and Rho GTPases: a family reunion. Cell 2000; 103: 227-238.
18. Coso OA, Teramoto H, Simonds WF, Gutkind JS. Signaling from G protein-coupled receptors to c-jun kinase involves βγ-subunits of heterotrimeric G proteins acting on a p21ras and rac1-dependent pathway. J Biol Chem 1996; 271: 3963-3966.
19. Tang W-J, Gilman AG. Type specific regulation of adenylyl cyclase by G-protein beta gamma subunits. Science 1991; 254: 1500-1503.
20. Reddy MA, Shukla, Shukla, SD. Potentiation of mitogen-activated protein kinase by ethanol in embryonic liver cells. Biochem Pharmacol 1996; 51: 661-668.
21. Poso H, Vaananen H, Salapuro MP, Poso AR. Effects of ethanol on liver regeneration after partial hepatectomy in rats. Med Biol 1980; 58: 329-336.
22. Dugay LD, Cuoter D, Hetu C, Jolly JG. Inhibition of liver regeneration by chronic alcohol administration. Gut 1982; 23: 8-13.
23. Frank WO, Rayes AN, Washington A, Holt PR. Effect of acute ethanol administration upon hepatic regeneration. J Lab Clin Med 1982; 93: 402-413.
24. Hoek JB, Thomas AP, Rubin R, Rubin E. Ethanol-induced mobilization of calcium by activation of phosphoinositide-specific phospholipase C in intact hepatocytes. J Biol Chem 1987; 262: 682-691.
25. Hoek JB, Thomas AP, Rooney TA, Higashi K, Rubin E. Ethanol and signal transduction in the liver. FASEB J 1992; 6: 2386-2396.
26. Rabin RA, Malinoff PB. Multiple sites of action of ethanol on adenylate cyclase. J Pharmacol Exp Therap 1983; 227: 551-556.
27. Diehl AM, Bisgaard HC, Kren BT, Steer, Steer, CJ. Chronic ethanol consumption disturbs G-protein expression and inhibits cyclic AMP-dependent signaling in regenerating rat liver. Hepatology 1992; 16: 1212-1219.
28. Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol 1976; 13: 29-83.
29. Evans MJ, Kovacs CJ. Properties of the H-4-II-E tumor cell system. I. Growth and cell proliferation kinetics of an experimental hepatoma. Cell Tissue Kinet 1977; 10: 233.233.
30. Columbano A, Shinozuka H. Liver regeneration versus direct hyperplasia. FASEB J 1996; 10: 1118-1128.
31. Lieber CS, Leo MA. Metabolism of ethanol and some associated adverse effects on the liver and the stomach. Recent Dev Alcohol 1998; 14: 7-40.
32. Dicker E, Cederbaum AI. Generation of reactive oxygen species and reduction of ferric chelates by microsomes in the presence of a reconstituted system containing ethanol, NAD+ and alcohol dehydrogenase. Alcohol Clin Exp Res 1990; 2: 238-244.
33. Lieber CS. Ethanol metabolism, cirrhosis and alcoholism. Clin Chim Acta 1997; 257: 59-84.
34. Crabb DW. Ethanol oxidizing enzymes: roles in alcohol metabolism and alcoholic liver disease. Prog Liver Dis 1995; 13: 151-157.
35. Lieber CS. Cytochrome P-4502E1: its physiological and pathological role. Physiol Rev 1997; 77: 517-524.
36. Muller A, Sies H. Alcohol, aldehydes and lipid peroxidation: current notions. Alcohol 1987; 1 (suppl): 67-74.
37. Ekstrom G, Ingelman-Sundberg M. Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1). Biochem Pharmacol 1989; 38: 1313-1319.
38. Djordjevic D, Nikolic J, Stefanovic V. Ethanol interactions with other cytochrome P450 substrates including drugs, xenobiotics, and carcinogens. Pathol Biol 1998; 46: 760-770.
39. Albano E, French SW, Ingelman-Sundberg M. Hydroxyethyl radicals in ethanol hepatotoxicity. Front Biosci 1999; 4: D533-D540.
40. Wu D, Cederbaum AI. Ethanol-induced apoptosis to stable HepG2 cell lines expressing human cytochrome P-4502E1. Alcohol Clin Exp Res 1999; 23: 67-76.
41. Cho KJ, Jang JJ. Effects of carbon tetrachloride, ethanol and acetaldehyde on diethylnitrosamine-induced hepatocarcinogenesis in rats. Cancer Lett 1993; 70: 33-39.